EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis
IRVINE, Calif., March 23, 2026 /PRNewswire/ — EndoCyclic Therapeutics, a biopharmaceutical company developing precision peptide therapeutics and diagnostics…